BiomX Inc. — Director's Dealing 2024

Jul 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2024-07-11

Reporting Person: Solomon Jonathan Eitan (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-07-11	Common Stock Options - Right to Buy	$0.363	A	3805000	Acquired	2034-07-11	Common Stock (3805000)	Direct

Footnotes

F1: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on July 11, 2025, and the remainder vesting in 12 equal quarterly installments over three years.